About 528,000 results
Open links in new tab
Study: Diabetes Drug May Cut Risk of Alzheimer’s and Parkinson’s …
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in …
FDA Update: Sotagliflozin Approved For Broad HF Treatment
FDA approves first SGLT1/SGLT2 inhibitor for heart failure
SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective …
SGLT2 inhibitor empagliflozin is shown to be safe and effective for ...
KDIGO provided recommendations on SGLT2 inhibitors and …
SGLT2 Inhibitor Use in Stage 5 CKD Cuts Risks for Cardiovascular ...
SGLT2 inhibitors in CKD and HFpEF: two new large trials and two …
Applications of SGLT2 inhibitors beyond glycaemic control